178 related articles for article (PubMed ID: 31351988)
1. The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation.
Mahrooz A; Mackness M; Bagheri A; Ghaffari-Cherati M; Masoumi P
Clin Biochem; 2019 Nov; 73():1-10. PubMed ID: 31351988
[TBL] [Abstract][Full Text] [Related]
2. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.
James RW; Deakin SP
Free Radic Biol Med; 2004 Dec; 37(12):1986-94. PubMed ID: 15544917
[TBL] [Abstract][Full Text] [Related]
3. Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection.
Khalil A; Fulop T; Berrougui H
Antioxid Redox Signal; 2021 Jan; 34(3):191-200. PubMed ID: 31969002
[No Abstract] [Full Text] [Related]
4. Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme.
Mahrooz A
Curr Clin Pharmacol; 2016; 11(4):259-264. PubMed ID: 27633038
[TBL] [Abstract][Full Text] [Related]
5. The paraoxonase 1, 2 and 3 in humans.
Rajkovic MG; Rumora L; Barisic K
Biochem Med (Zagreb); 2011; 21(2):122-30. PubMed ID: 22135851
[TBL] [Abstract][Full Text] [Related]
6. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase, a cardioprotective enzyme: continuing issues.
Getz GS; Reardon CA
Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
[TBL] [Abstract][Full Text] [Related]
8. Variation in paraoxonase-1 activity and atherosclerosis.
Soran H; Younis NN; Charlton-Menys V; Durrington P
Curr Opin Lipidol; 2009 Aug; 20(4):265-74. PubMed ID: 19550323
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic functions and clinical importance of circulating HDL-PON1 complex.
Mahrooz A
Adv Clin Chem; 2024; 121():132-171. PubMed ID: 38797541
[TBL] [Abstract][Full Text] [Related]
10. Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review.
Kunachowicz D; Ściskalska M; Kepinska M
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833509
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics of paraoxonases.
Mahrooz A; Mackness M
Curr Opin Lipidol; 2020 Aug; 31(4):200-205. PubMed ID: 32487820
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
Kim DS; Marsillach J; Furlong CE; Jarvik GP
Pharmacogenomics; 2013 Sep; 14(12):1495-515. PubMed ID: 24024900
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
Rosenblat M; Karry R; Aviram M
Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
[TBL] [Abstract][Full Text] [Related]
14. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
[TBL] [Abstract][Full Text] [Related]
15. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae.
Soran H; Schofield JD; Liu Y; Durrington PN
Curr Opin Lipidol; 2015 Aug; 26(4):247-56. PubMed ID: 26103614
[TBL] [Abstract][Full Text] [Related]
16. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
17. A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.
Petrič B; Kunej T; Bavec A
OMICS; 2021 Jan; 25(1):38-51. PubMed ID: 33306925
[TBL] [Abstract][Full Text] [Related]
18. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.
Holland N; Lizarraga D; Huen K
Curr Opin Pediatr; 2015 Apr; 27(2):240-7. PubMed ID: 25635583
[TBL] [Abstract][Full Text] [Related]
20. Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.
Shokri Y; Variji A; Nosrati M; Khonakdar-Tarsi A; Kianmehr A; Kashi Z; Bahar A; Bagheri A; Mahrooz A
Diabetes Res Clin Pract; 2020 Mar; 161():108067. PubMed ID: 32044348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
